Core Insights - The event "Yoyo Deer City Surrounding, Enjoying Health" was co-hosted by Tieling Municipal Government and China Resources Pharmaceutical Group, marking a significant step towards the internationalization of China's deer industry [1] - The conference gathered 25 key cities in the deer industry to enhance cooperation and promote transformation and upgrading of the deer industry, contributing to the revitalization of traditional Chinese medicine and the development of the health industry [1] Industry Developments - An international deer trade port cooperation agreement was signed between Xifeng County and Dong'e Ejiao, as well as the New Zealand Deer Industry Association, aiming to create a global distribution center for deer products [1] - The establishment of the Deer Industry Professional Committee under the China Agricultural International Exchange Association aims to shift the deer industry from decentralized operations to intensive development and from traditional models to modern, international practices [1] Technological Advancements - The launch of the first digital deer industry ecological platform, "Deer Internet," is intended to promote industry integration through digital means and build a sustainable development ecosystem [1] - Nine key projects were signed on-site during the conference, covering areas such as cold chain logistics, deep processing, and digital platforms, with a total investment exceeding 10 billion yuan [1]

Core Insights - The article emphasizes the significance of traditional Chinese brands, known as "Chinese Time-honored Brands," which embody the essence of Chinese culture and have evolved through innovation over centuries [1][2]. Group 1: Current Status of Chinese Time-honored Brands - The Ministry of Commerce has recognized a total of 1,450 Chinese Time-honored Brands [2]. - Recent events, such as the International Exchange Activity and the Fifth Innovation Development Conference, have brought together representatives from various brands to explore new paths for innovation and collaboration [2]. Group 2: Commitment to Craftsmanship - The enduring success of Time-honored Brands is attributed to their commitment to craftsmanship and cultural heritage, which are closely linked to the nation's economy and people's livelihoods [3]. - Brands like Liu Bi Ju and Tong Ren Tang exemplify this commitment through their dedication to quality and ethical practices [3]. - Dong'e Ejiao has maintained its unique production techniques for nearly 3,000 years, emphasizing the importance of preserving traditional methods while modernizing [3]. Group 3: Innovation and Market Adaptation - Time-honored Brands are actively adapting to market demands by embracing innovation, targeting younger consumers, and leveraging digital technologies [4][5]. - Dong'e Ejiao has successfully transformed its image from an "elderly brand" to a trendy national brand by collaborating with popular tea brands and launching products that appeal to younger audiences [5][6]. - China Tea Company has focused on optimizing product flavors and modernizing packaging to attract younger consumers [6]. Group 4: Digital Transformation - The digital transformation of Time-honored Brands is crucial for their evolution, with Dong'e Ejiao achieving a digitalization level that meets the highest standards [6]. - The online business of Dong'e Ejiao now accounts for nearly 30% of its overall operations, showcasing the impact of digital strategies [6]. - China Tea Company is implementing digital controls across the entire supply chain, from cultivation to processing [7]. Group 5: Cultural Export and Global Reach - Time-honored Brands are becoming important vehicles for cultural export, with Tong Ren Tang expanding its presence globally since the 1990s [7]. - Dong'e Ejiao has participated in international conferences to promote traditional Chinese medicine, indicating a growing acceptance of Chinese culture abroad [7]. - China Tea Company aims to share Chinese culture through tea, enhancing global consumer experiences with Chinese lifestyle and values [7].

Core Viewpoint - The company announced a collaboration with Shanghai University of Traditional Chinese Medicine to establish the "Dong'e Ejiao Scholarship," with a total donation of 750,000 yuan over five years, aimed at promoting research and innovation in traditional Chinese medicine [2][2][2] Group 1: Donation and Collaboration - The company’s board approved a proposal for external donations, focusing on the establishment of a scholarship to support students [2][2] - The collaboration will concentrate on research in gelatin-based medicines, formulation standards, talent cultivation, and the innovation of traditional Chinese medicine culture [2][2] Group 2: Financial Impact - The donation is not expected to have a significant impact on the company's current or future financial status and will not affect normal production and operations [2][2] - For the first three quarters, the company reported total revenue of 4.766 billion yuan, a year-on-year increase of 4.41%, and a net profit attributable to shareholders of 1.274 billion yuan, up 10.53% year-on-year [2][2]

Core Viewpoint - Dong'e Ejiao announced the nomination of Wang Yifei as a non-independent director candidate for the company's 11th board of directors [2] Group 1 - The board of directors of Dong'e Ejiao has approved the nomination of Wang Yifei by the controlling shareholder [2]

证券代码：000423 证券简称：东阿阿胶 公告编号：2025-62 为进一步提升公司规范运作水平，完善公司治理结构，根据《公司法》《上 市公司章程指引》《上市公司信息披露管理办法》《深圳证券交易所股票上市规 则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》 等法律、行政法规、部门规章、规范性文件及《公司章程》等相关规定，结合公 司实际情况，对现有的部分公司治理制度进行修订，同时新增制定相关制度。具 体修订、制定情况如下： | 序号 | 制度名称 | 类别 | 是否需股东 大会审议 | | --- | --- | --- | --- | | 1 | 《股东会议事规则》 | 修订 | 是 | | 2 | 《董事会议事规则》 | 修订 | 是 | | 3 | 《董事会战略委员会实施细则》 | 修订 | 否 | | 4 | 《董事会提名委员会实施细则》 | 修订 | 否 | | 5 | 《董事会审计委员会实施细则》 | 修订 | 否 | | 6 | 《董事会薪酬与考核委员会实施细则》 | 修订 | 否 | | 7 | 《董事会授权管理制度》 | 修订 | 否 | | 8 | 《独立董事工 ...

证券代码：000423 证券简称：东阿阿胶 公告编号：2025-66 东阿阿胶股份有限公司 （1）现场会议时间：2025年11月28日09:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025年11月28日9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互 联网投票系统投票的具体时间为2025年11月28日9:15至15:00的任意时间。 5．会议的召开方式：采用现场表决与网络投票相结合 （1）现场表决：股东本人或委托他人出席现场会议； 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1．股东大会届次：2025年第一次临时股东大会 2．股东大会的召集人：董事会 3．会议召开的合法合规性：本次股东大会会议的召开，符合有关法律、行 政法规、部门规章、规范性文件、深交所业务规则和《公司章程》等规定。 4．会议时间： 关于召开 2025 年第一次临时股东大会的通知 （2）网络投票：公司通过深圳证券交易所交易系统和互联网投票系统向全 体股东提供网络形式的投票平台，股东可以在网络投票 ...

证券代码：000423 证券简称：东阿阿胶 公告编号：2025-60 东阿阿胶股份有限公司 第十一届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 表决结果：5 票同意，0 票反对，0 票弃权。 3．会议应出席会议监事 5 人，实际出席会议监事 5 人。 4．本次监事会会议的召开，符合有关法律、行政法规、部门规章、规范性 文件和公司章程等规定。 二、监事会会议审议情况 本次会议审议并通过了以下议案： 《关于预计 2026 年度日常关联交易额的议案》 经审议，2026 年日常关联交易预计为公司正常经营需要，交易金额预计客 观、合理，保证了公司持续稳定发展，不存在损害上市公司及其股东特别是中小 股东利益的情形。公司董事会在审议关联交易事项时，程序合法，关联董事进行 了回避表决，符合《公司法》《深圳证券交易所股票上市规则》等法律法规及规 范性文件和《公司章程》等规定。 本事项具体内容，详见公司同日披露于巨潮资讯网（www.cninfo.com.cn） 的《2026 年度日常关联交易预计公告》（公告编号：2025-63）。 一、监事会会议召 ...

证券代码：000423 证券简称：东阿阿胶 公告编号：2025-59 东阿阿胶股份有限公司 第十一届董事会第十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 4．本次董事会会议的召开，符合有关法律、行政法规、部门规章、规范性 文件和公司章程等规定。 二、董事会会议审议情况 本次会议审议并通过了以下议案： 1．《关于修订<公司章程>的议案》 为进一步提升公司规范运作水平，完善公司治理结构，根据《公司法》《上 市公司章程指引》《深圳证券交易所股票上市规则》《深圳证券交易所上市公 司自律监管指引第 1 号——主板上市公司规范运作》等法律、行政法规、部门 规章、规范性文件的相关规定，结合公司实际情况，拟对《公司章程》相关条 款进行修订。本次修订内容主要包括完善总则、法定代表人、股份发行等规定， 完善股东、股东会相关制度，完善董事、董事会及专门委员会的要求，取消监 事及监事会制度及相关措辞修改等。 本次《公司章程》修订经股东大会审议通过后，公司将不再设置监事会和 监事，由董事会审计委员会行使《公司法》规定的监事会的职权，公司《监事 会议事规则》相应废止 ...

Core Viewpoint - Dong'e Ejiao announced the resignation of two board members due to job changes, which may impact the company's governance structure and strategic direction [1] Company Updates - Wang Xiaoyue and Yu Xiaohui have resigned from their positions on the 11th Board of Directors and various committees, and they will continue to hold positions at China Resources Pharmaceutical Group [1] - As of the latest report, Dong'e Ejiao's market capitalization stands at 31.7 billion yuan [1] Financial Performance - For the first half of 2025, Dong'e Ejiao's revenue composition is as follows: pharmaceutical industry accounts for 97.88%, donkey breeding and trade for 1.11%, and other industries for 1.01% [1]

Core Viewpoint - Dong'e Ejiao (000423.SZ) is collaborating with Shanghai University of Traditional Chinese Medicine to enhance the integration of traditional Chinese medicine with technology and industry upgrades [1] Group 1: Collaboration Details - The collaboration focuses on research related to gelatin-based medicines and medicinal pastes, the establishment of international standards, talent cultivation, and the inheritance and innovation of traditional Chinese medicine culture [1] - The partnership is set for a duration of five years, during which the company will provide an annual scholarship of 150,000 yuan to the university, totaling 750,000 yuan over the entire period [1] Group 2: Regulatory Aspects - According to the Shenzhen Stock Exchange listing rules and the company's articles of association, this proposal does not require submission for shareholder meeting approval [1]